9AT: SYMBIOTIC CAPITAL

other names

SYMBIOTIC CAPITAL
SYMBIOTIC CAPITAL MANAGEMENT CO. LLC

Adviser Profile

As of Date	09/05/2025
ADV Location	LOS ANGELES, CA, United States
Adviser Type - Large advisory firm
Number of Employees	6 20%
of those in investment advisory functions	6 50%
Registration	SEC, Approved, 07/28/2023
Other registrations (4)	SEC, ERA - Withdrawn, 06/28/2023 California, ERA - Withdrawn, 06/28/2023 SEC, ERA - Active, 06/01/2023 California, ERA - Active, 06/01/2023
Former registrations	SYMBIOTIC CAPITAL MANAGEMENT CO. LLC

AUM^*	839,442,588 281%
of that, discretionary	839,442,588 281%
Private Fund GAV^*	839,442,588 232%
Avg Account Size	167,888,518 53%
SMA’s	No
Private Funds	9 7
Contact Info	424 xxxxxxx
Websites

Client Types

- Pooled investment vehicles

Advisory Activities

- Portfolio management for pooled investment vehicles

Compensation Arrangments

- A percentage of assets under your management
- Performance-based fees

Fund Type	Count	GAV
Fund TypeOther Private Fund	Count9	GAV$839,442,588

Adviser	Hedge Fund	Liquidity Fund	Private Equity Fund	Real Estate Fund	Securitized Asset Fund	Venture Capital Fund	Other Fund	Total Private Fund GAV	AUM	#Funds
Adviser GLL INVESTORS	Hedge Fund-	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund188.9m	Total Private Fund GAV188.9m	AUM188.9m	#Funds7
Adviser KARLOV STREET CAPITAL, LLC	Hedge Fund-	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund229.8m	Total Private Fund GAV229.8m	AUM234.4m	#Funds31
Adviser VIRTERA PARTNERS LLC	Hedge Fund-	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund30.0m	Other Fund198.4m	Total Private Fund GAV258.4m	AUM452.1m	#Funds8
Adviser CRESCENDO ASSET MANAGEMENT LLC	Hedge Fund-	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV-	AUM184.5m	#Funds-
Adviser MONTCALM TCR LLC	Hedge Fund-	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund834.2k	Total Private Fund GAV834.2k	AUM223.4m	#Funds1
Adviser PAN GLOBAL ADVISERS, LLC	Hedge Fund-	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund19.5m	Total Private Fund GAV19.5m	AUM225.7m	#Funds1
Adviser MASON CAPITAL PARTNERS	Hedge Fund-	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund83.5m	Total Private Fund GAV83.5m	AUM202.0m	#Funds2
Adviser PRESERVER PARTNERS	Hedge Fund-	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund149.6m	Total Private Fund GAV149.6m	AUM157.8m	#Funds2
Adviser VCFA GROUP	Hedge Fund-	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund560.3m	Total Private Fund GAV560.3m	AUM415.9m	#Funds10
Adviser STOCK FARM PARTNERS LLC	Hedge Fund-	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund136.5m	Total Private Fund GAV136.5m	AUM136.5m	#Funds3

Brochure Summary

Overview

Symbiotic Capital Management Co. LLC (“Symbiotic Capital,” the “Adviser,” “our,” or “we”) is a Delaware limited liability company located in Los Angeles, California, and founded in September 2022 by Symbiotic Capital, LLC. Symbiotic Capital is a first-of-its-kind life science credit platform and aspires to be the preferred credit partner for innovative life science companies. The Adviser is backed by Bellco Capital LLC’s (“Bellco Capital”) preeminent life science ecosystem, which, over the past three decades, has incubated and built leading life science companies (such as Kite Pharma), invested in transformational science, and developed life science real estate across the globe. Symbiotic Capital’s participation in this ecosystem actively empowers our investment sourcing and portfolio value creation. In addition, Symbiotic Capital has access to numerous companies, academia, investors, and pharma partners via the Bellco Capital life science ecosystem and will seek to leverage these relationships across all aspects of the credit business, from deal sourcing to adding

value to the underlying borrowers. Symbiotic Capital provides advisory services to the Symbiotic Life Sciences Credit Fund and the Symbiotic Capital Life Science Credit Parallel Fund GP, L.P. (the “Funds” or the “Clients”). The Funds offer investors the opportunity to own a curated portfolio of secured credit investments in the development stage and commercial stage life science companies. Symbiotic Capital focuses on looking for opportunities to enhance borrower value through the life of the loan and, as necessary, to leverage its life science heritage and ecosystem to manage downside scenarios. As of December 2023, Symbiotic Capital has $252,499,111 in discretionary assets under management. Persons reviewing this Form ADV Part 2A should not construe this as an offering of the Funds described herein, which will only be made pursuant to the delivery of a private placement memorandum, subscription agreement, and/or similar documentation to prospective investors. Symbiotic Capital does not participate in wrap fee programs or advise client assets on a non- discretionary basis.

SYMBIOTIC CAPITAL

Related Companies

Adviser Profile

Details

Client Types

Advisory Activities

Compensation Arrangments

Reported AUM

Private Funds

Employees

Private Funds Structure

Similar advisers

Brochure Summary

Overview